Your browser doesn't support javascript.
loading
Course and Moderators of Hot Flash Interference during Androgen Deprivation Therapy for Prostate Cancer: A Matched Comparison.
Gonzalez, Brian D; Jim, Heather S L; Donovan, Kristine A; Small, Brent J; Sutton, Steve K; Park, Jong; Lin, Hui-Yi; Spiess, Philippe E; Fishman, Mayer N; Jacobsen, Paul B.
Afiliación
  • Gonzalez BD; Health Outcomes and Behavior Program, Moffitt Cancer Center, Tampa, Florida; Supportive Care Medicine, Moffitt Cancer Center, Tampa, Florida; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, Florida; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florid
  • Jim HS; Health Outcomes and Behavior Program, Moffitt Cancer Center, Tampa, Florida; Supportive Care Medicine, Moffitt Cancer Center, Tampa, Florida; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, Florida; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florid
  • Donovan KA; Health Outcomes and Behavior Program, Moffitt Cancer Center, Tampa, Florida; Supportive Care Medicine, Moffitt Cancer Center, Tampa, Florida; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, Florida; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florid
  • Small BJ; Health Outcomes and Behavior Program, Moffitt Cancer Center, Tampa, Florida; Supportive Care Medicine, Moffitt Cancer Center, Tampa, Florida; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, Florida; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florid
  • Sutton SK; Health Outcomes and Behavior Program, Moffitt Cancer Center, Tampa, Florida; Supportive Care Medicine, Moffitt Cancer Center, Tampa, Florida; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, Florida; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florid
  • Park J; Health Outcomes and Behavior Program, Moffitt Cancer Center, Tampa, Florida; Supportive Care Medicine, Moffitt Cancer Center, Tampa, Florida; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, Florida; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florid
  • Lin HY; Health Outcomes and Behavior Program, Moffitt Cancer Center, Tampa, Florida; Supportive Care Medicine, Moffitt Cancer Center, Tampa, Florida; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, Florida; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florid
  • Spiess PE; Health Outcomes and Behavior Program, Moffitt Cancer Center, Tampa, Florida; Supportive Care Medicine, Moffitt Cancer Center, Tampa, Florida; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, Florida; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florid
  • Fishman MN; Health Outcomes and Behavior Program, Moffitt Cancer Center, Tampa, Florida; Supportive Care Medicine, Moffitt Cancer Center, Tampa, Florida; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, Florida; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florid
  • Jacobsen PB; Health Outcomes and Behavior Program, Moffitt Cancer Center, Tampa, Florida; Supportive Care Medicine, Moffitt Cancer Center, Tampa, Florida; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, Florida; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florid
J Urol ; 194(3): 690-5, 2015 Sep.
Article en En | MEDLINE | ID: mdl-25791402
ABSTRACT

PURPOSE:

Many men receiving androgen deprivation therapy for prostate cancer experience hot flashes. This study aimed to describe the course of hot flash interference with time in androgen deprivation therapy recipients relative to matched prostate cancer and cancer-free controls from before the start of androgen deprivation therapy to 12 months later. We also examined demographic, clinical and genetic predictors of the impact of androgen deprivation therapy on hot flash interference. MATERIALS AND

METHODS:

Three groups were examined, including 60 patients with prostate cancer recruited before or within 21 days of starting androgen deprivation therapy, 83 age and education matched patients with prostate cancer treated with prostatectomy only, and 86 age and education matched men with no history of cancer. Participants provided blood samples and completed the Hot Flash Related Daily Interference Scale at baseline as well as 6 and 12 months later.

RESULTS:

Androgen deprivation therapy recipients reported increasing hot flash interference with time relative to controls (p <0.001). Group differences were evident at 6 and 12 months (all p <0.001) with androgen deprivation therapy recipients reporting greater hot flash interference than controls. Several genetic polymorphisms were found to predict greater increases in hot flash interference (all p <0.01), including polymorphisms on genes associated with vasoconstriction, immune function, neurotransmission and circadian rhythms. Androgen deprivation therapy recipients who were younger and had a lower body mass index at baseline also showed greater increases in hot flash interference with time (all p ≤0.01).

CONCLUSIONS:

This study, which is to our knowledge the first to prospectively examine hot flash interference in androgen deprivation therapy recipients, reveals that those with certain genetic polymorphisms, younger age and lower body mass index had greater increases in hot flash interference with time relative to controls.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Sofocos / Antagonistas de Andrógenos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Aged / Humans / Male Idioma: En Revista: J Urol Año: 2015 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Sofocos / Antagonistas de Andrógenos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Aged / Humans / Male Idioma: En Revista: J Urol Año: 2015 Tipo del documento: Article